Summary Significant Accounting Policies Parentheticals (Details) (USD $)
|
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Amortization of deferred financing costs | $ 0 | $ 4,284 |
Costs of patents written off (ProAlgaZyme) | 6,234 | 0 |
Research Expenses - Salaries and equipment related expenses | 25,000 | 25,000 |
Clinical Studies expenses - fees, charges and related expenses | 104,000 | 77,000 |
Compensation expenses recorded | 6,037 | 10,722 |
Advertising/Public Relation costs charged to operating expenses | $ 7,461 | $ 9,496 |
X | ||||||||||
- Definition
Advertising/Public Relation costs charged to operating expenses No definition available.
|
X | ||||||||||
- Definition
Amortization of deferred financing costs No definition available.
|
X | ||||||||||
- Definition
Clinical Studies expenses - fees, charges and related expenses No definition available.
|
X | ||||||||||
- Definition
Compensation expenses recorded No definition available.
|
X | ||||||||||
- Definition
Costs of patents written off (ProAlgaZyme) No definition available.
|
X | ||||||||||
- Definition
Research Expenses - Salaries and equipment related expenses No definition available.
|